| Type | Value |
|---|---|
| cik | 0002096997 |
| ticker | KLRA |
Discretionary BUY minus SELL in USD over rolling windows. Excludes compensation flow.
Rolling 14-day windows where ≥3 distinct insiders reported a transaction in the same direction.
| Date | Direction | Insiders | Strength | Tx | USD |
|---|---|---|---|---|---|
| 20 Apr 2026 | buy | 5 | strong | 5 | $326.8M |
| Date | Type | Insider | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | CONVERSION | RTW Investments, LPentity | 10,276,820 | — | indirect |
| 20 Apr 2026 | CONVERSION | Jiangsu Hengrui Pharmaceuticals Co., Ltd.entity | 9,477,719 | — | |
| 20 Apr 2026 | CONVERSION | Jiangsu Hengrui Pharmaceuticals Co., Ltd.entity | 2,034,133 | — | |
| 20 Apr 2026 | CONVERSION | Jiangsu Hengrui Pharmaceuticals Co., Ltd.entity | 4,968,789 | 0.00 USD | deriv |
| 20 Apr 2026 | CONVERSION | Jiangsu Hengrui Pharmaceuticals Co., Ltd.entity | 708,814 | 0.00 USD | deriv |
| 20 Apr 2026 | PURCHASE | RTW Investments, LPentity | 500,000 | 16.00 USD | indirect |
| 20 Apr 2026 | CONVERSION | RTW Investments, LPentity | 8,250,000 | — | derivindirect |
| 20 Apr 2026 | CONVERSION | RTW Investments, LPentity | 2,026,820 | — | derivindirect |
| 16 Apr 2026 | GRANT_AWARD | Akamine Scott | 60,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Akamine Scott | 60,000 | 0.00 USD | deriv |
| 20 Apr 2026 | CONVERSION | BAIN CAPITAL INVESTORS LLCentity | 17,857,143 | — | indirect |
| 20 Apr 2026 | PURCHASE | BAIN CAPITAL INVESTORS LLCentity | 8,398,438 | 16.00 USD | indirect |
| 20 Apr 2026 | CONVERSION | BAIN CAPITAL INVESTORS LLCentity | 17,857,143 | 0.00 USD | derivindirect |
| 20 Apr 2026 | CONVERSION | Bain Capital Life Sciences Investors, LLCentity | 16,875,000 | — | indirect |
| 20 Apr 2026 | CONVERSION | Bain Capital Life Sciences Investors, LLCentity | 4,145,768 | — | indirect |
| 20 Apr 2026 | PURCHASE | Bain Capital Life Sciences Investors, LLCentity | 1,562,500 | 16.00 USD | indirect |
| 20 Apr 2026 | CONVERSION | Bain Capital Life Sciences Investors, LLCentity | 16,875,000 | 0.00 USD | derivindirect |
| 20 Apr 2026 | CONVERSION | Bain Capital Life Sciences Investors, LLCentity | 4,145,768 | 0.00 USD | derivindirect |
| 16 Apr 2026 | GRANT_AWARD | Burgess Paul D. | 100,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Burgess Paul D. | 100,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Cloghessy Paula | 60,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Cloghessy Paula | 60,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Clyburn Frank | 38,300 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Coleman Jamie Beth | 75,000 | 0.00 USD | deriv |
| 16 Apr 2026 | GRANT_AWARD | Coleman Jamie Beth | 75,000 | 0.00 USD | deriv |